These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6813129

  • 1. Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants.
    Holcomb HH, Bannon MJ, Roth RH.
    Eur J Pharmacol; 1982 Aug 27; 82(3-4):173-8. PubMed ID: 6813129
    [Abstract] [Full Text] [Related]

  • 2. Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.
    Diggory GL, Buckett WR.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):257-63. PubMed ID: 6510470
    [Abstract] [Full Text] [Related]

  • 3. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A, Fadda F, Melis MR, Marcou M, Porceddu ML, Gessa GL.
    Eur J Pharmacol; 1982 Nov 05; 85(1):23-7. PubMed ID: 6818043
    [Abstract] [Full Text] [Related]

  • 4. Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
    Reches A, Wagner HR, Jackson-Lewis V, Fahn S.
    Brain Res; 1985 Nov 18; 347(2):346-9. PubMed ID: 3933764
    [Abstract] [Full Text] [Related]

  • 5. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M, White FJ.
    Synapse; 1989 Nov 18; 4(4):267-80. PubMed ID: 2603146
    [Abstract] [Full Text] [Related]

  • 6. Reduced apomorphine sensitivity of dopamine metabolism in rat striatum after repeated administration of methamphetamine.
    Kashihara K, Sato M, Fukuda K, Fujiwara Y, Otsuki S.
    Neurosci Res; 1986 May 18; 3(4):351-5. PubMed ID: 3725224
    [Abstract] [Full Text] [Related]

  • 7. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S, Watanabe A, Takahashi R.
    Eur J Pharmacol; 1986 Apr 16; 123(2):287-94. PubMed ID: 3086109
    [Abstract] [Full Text] [Related]

  • 8. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC, de Vries JB, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 16; 327(4):304-11. PubMed ID: 6514014
    [Abstract] [Full Text] [Related]

  • 9. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun 16; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 10. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
    Globus M, Melamed E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1983 Jun 16; 7(2-3):211-5. PubMed ID: 6310691
    [Abstract] [Full Text] [Related]

  • 11. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jun 16; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 12. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R, Leith NJ, Applegate CD.
    Brain Res; 1983 Jan 10; 258(2):333-7. PubMed ID: 6824917
    [Abstract] [Full Text] [Related]

  • 13. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb 10; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 14. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum.
    Guo X, Chen LJ, Buda M, Jin GZ.
    Zhongguo Yao Li Xue Bao; 1992 Jul 10; 13(4):289-92. PubMed ID: 1360740
    [Abstract] [Full Text] [Related]

  • 15. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar 10; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 16. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ, Marsh ER, Kula NS, Zong RS, Gao YG, Neumeyer JL.
    Biochem Pharmacol; 1990 Aug 01; 40(3):417-23. PubMed ID: 2383279
    [Abstract] [Full Text] [Related]

  • 17. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C, De Lucia R, Bernardi MM, Aizenstein ML.
    Eur J Pharmacol; 1985 May 28; 112(1):11-6. PubMed ID: 4040467
    [Abstract] [Full Text] [Related]

  • 18. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E.
    Mol Pharmacol; 1999 Feb 28; 55(2):202-9. PubMed ID: 9927609
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984 Feb 28; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 20. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.